[Correspondence] Drawing conclusions from the VIVA trial

The VIVA trial by Jes Lindholt and Rikke S øgaard (Nov 18, 2017, p 2256)1 assessed the effects of screening for abdominal aortic aneurysm, peripheral arterial disease, and hypertension, showing a small but statistically significant reduction in total mortality in the screening group versus the non-screening group. The authors concluded that “the observed reduction of mortality risk from abdominal aortic aneurysm, peripheral arterial disease, and hypertension” should lead policy makers to “consider implementing combined screening”.

Source: LANCET - May 11, 2018 Category: General Medicine Authors: Karsten Juhl J ørgensen, Minna Johansson Tags: Correspondence Source Type: research